The pattern electroretinogram (PERG) has now been in routine clinical use for sufficiently long to allow a personal clinical review of its relationship to the cortically generated pattern visual evoked potential (PVEP). The Although Riggs and co-workers1 first reported that small retinal potentials are evoked when a pattern is reversed in contrast, the development of the Arden gold foil corneal electrode, 2 synchronous with the introduction of the DTL thread electrode, 3 facilitated the introduction of the pattern electroretinogram (PERG) into routine clinical practice. This paper offers a personal clinical review of the PERG, as this test has now been in routine use in the author's laboratory for more than 10 years, and has become an invaluable part of the diagnostic armamentarium. The review examines the use of the PERG in conjunction with the pattern visual evoked potential A steady-state response can be obtained by using a faster reversal rate. An 8 Hz stimulus rate (i.e. 16 reversals per second) is commonly used. The measurement of individual components is not pos sible with steady-state recording, and although it may be a useful research tool, this limits its routine clinical use; the steady-state PERG will not be further discussed in detail.
(PVEP). The PERG and PVEP findings are presented from 520 eyes with optic nerve demyelination (382 eyes), optic nerve compression (90 eyes) or here do familial optic atrophy (48 Although Riggs and co-workers1 first reported that small retinal potentials are evoked when a pattern is reversed in contrast, the development of the Arden gold foil corneal electrode, 2 synchronous with the introduction of the DTL thread electrode, 3 facilitated the introduction of the pattern electroretinogram (PERG) into routine clinical practice. This paper offers a personal clinical review of the PERG, as this test has now been in routine use in the author's laboratory for more than 10 years, and has become an invaluable part of the diagnostic armamentarium. The review examines the use of the PERG in conjunction with the pattern visual evoked potential (PVEP) in the assessment of macular and optic nerve function. After a summary and review of the PERG and PVEP results in various conditions, a diagnostic strategy is presented.
There are two main approaches for recording a PERG: transient and steady state. The transient PERG is a discrete response obtained with a stimulus rate of less than 7 reversals per second. The main components of the transient PERG are a positive component, P50, at approximately 50 ms and a larger negative component, N95, at some 95 ms. 4 , 5 Many subjects have a small early negativity (N35) at 30-35 ms. A steady-state response can be obtained by using a faster reversal rate. An 8 Hz stimulus rate (i.e. 16 reversals per second) is commonly used. The measurement of individual components is not pos sible with steady-state recording, and although it may be a useful research tool, this limits its routine clinical use; the steady-state PERG will not be further discussed in detail.
Both the PERG P50 component and the b-wave of the ERG are positive components, and it is perhaps this superficial waveform similarity that led many early workers on the origins of the PERG, and much early clinical work, to examine this component in isolation. There were no conclusive data (for review see Berninger and Arden 6 ). Some animal work implicated the ganglion cells?, 8 but the failure of some authors9,10 to observe low spatial frequency attenuation of the P50 component of the PERG in man was against this. Indeed, at one stage Spekreijse's group proposed that the PERG may simply be a summation of local luminance changes.u Our perceptions changed when attention was focused on both the P50 and N95 components of the PERG. Berninger and Schuurmans12,13 found Eye (1997) 11,924-934 © 1997 Royal College of Ophthalmologists that although the P50 component failed to show spatial tuning, this was present for the N95 compo nent, suggesting a ganglion cell site of origin for N95, but not necessarily for P50. They suggested that N95 was a contrast-dependent component, but that there was a significant luminance contribution to P50. Spekreijse's group later showed that at least 50% of the PERG is contrast related for check sizes subtending less than 120' of arc.1 4 Drasdo's group, with Arden, 1 5 extracted the 'pattern specific response' (PSR) 16 from the PERG and demonstrated a correlation between the amplitude of the negative PSR (N95 equivalent) and the volume of the ganglion cell layer, providing further experimental evidence for a ganglion cell origin for N95.
Over the same period, the clinical observations that P50 and N95 may be selectively affected in disease processes 4 , 1 ?-19 provided clinical evidence in keeping with Berninger and Schuurmans' suggestion that the two main components may have different origins. Following this, Celesia's group, 20 using a cat model, demonstrated that the effect of optic nerve section was more marked on the late negative (N95 equivalent) than the positive component; there are, however, problems when extrapolating from cat retina to human. Overall, it seems probable that N95 and some of P50 are ganglion cell derived, but that there may be a contribution to the P50 component from more distal retina.
TECHNICAL CONSIDERATIONS AND METHODOLOGY
The development of the Arden gold foil electrode 2 and the DTL fibre electrode 3 made PERG recording a clinically feasible proposition. Both are relatively easy to apply with minimal risk of trauma to the cornea and leave the optics of the eye unimpairedessential when viewing a structured stimulus. Topical anaesthesia is not usually required, and is probably contraindicated. 21 The practical details of gold foiF2 and DTL 23 electrode application are described else where. The positional stability of the gold foil electrode (when correctly applied) is probably greater than that of the DTL, but requires greater experience to attain competence in application. Surface electrodes cannot be recommended for routine use due to the marked and variable degree of amplitude attenuation, but may have a role in paediatric practice. Although there have been claims that the trial-to-trial variability of the PERG is too great for it to be a clinically useful tool, 24 or that the gold foil is an unsatisfactory electrode, 25 All PERG data presented in this review were obtained using Arden gold foil electrodes in relation to ipsilateral outer canthus reference electrodes (silver/silver chloride). Bandpass was 1-100 Hz, artefact reject was 60 f.L V peak-to-peak, analysis time was 180 ms, there were a minimum of 150 averages per trial, often more, and a minimum of two trials. The stimulus was a black and white moving mirror checkerboard subtending a total field of 14° with an individual check size of 34 minutes of arc. There was a central luminance of 400 cd/m 2 , dropping off to 200 cd/m 2 at the corners. All recordings were taken binocularly using the 'inter rupted stimulation' technique previously described, 26 and a stimulus rate of 4.8 reversals/s (2.4 Hz). The appropriate refraction was used.
All PVEP data were obtained using the same stimulator, but with 26 minutes of arc checks in a 13° total field. Electrodes were placed according to the Modified Maudsley system of electrode placement as previously described?? Bandpass was 1-100 Hz, artefact reject was 100 f.L V peak-to-peak, analysis time was 400 ms, there were a minimum of 100 averages per trial, often more, and a minimum of two trials. All recordings were taken monocularly using a stimulus rate of 1.95 reversals/so The appropriate refraction was used.
RESULTS AND DISCUSSION
Given the nature of this paper, an approach to the data that combines Results and Discussion for the different disease categories has been adopted.
Retinal and Macular Disease
The PERG findings from a large group of patients (223 eyes) with generalised retinal or macular disease are shown in Figs. 1 and 2 in relation to the latency of the P100 component of the PVEP. They are patients either with dysfunction confined to the macula (e.g. macular dystrophy, central serous retinopathy), or with macular involvement as part of generalised retinal dysfunction (e.g. retinal dystrophy, inflamma tory retinopathy). The data in these, and subsequent figures, are presented as both the absolute values of the P50 component amplitude, and also the ratio between the N95 component amplitude and the P50 component amplitude. The N95:P50 ratio remains normal if a reduction in P50 is reflected in N95, but will be reduced if there is selective loss of the N95 component.
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PVEP P100 latency (msec, non-llnear) Note that the PSO component of the PERG is usually subnormal in these eyes, particularly when the PVEP is delayed (PVEP P100 component latency > lOS ms); it is clear that there is a tendency towards a lower PSO component amplitude in relation to an increasing PVEP PlOO component latency. Many patients have extinguished PERGs, particularly when there is a marked PVEP latency delay. Also note that some patients have an abnormal PSO component amplitude but a normal PVEP P100 component latency; the PERG PSO component is a more sensitive indicator of macular dysfunction than PVEP latency.
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The PERG PSO component, or the overall amplitude of the steady-state PERG (which pre cludes individual component assessment), was the focus of attention in the early reports of PERG changes in macular dysfunction,2 8 -32 all authors finding amplitude reduction with extinction in the more severe cases. This view did not change when the focus expanded to include both PSO and N9S 4 .1 9 , 33 -the N9S component usually showed a degree of amplitude reduction similar in proportion to PSO. The present data ( .'
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• cantly reduced, thereby giving a high N95:P50 ratio. The significance of this is uncertain. It is of particular importance that when the PVEP is delayed in disease distal (anterior) to the retinal ganglion cells, the P50 component of the PERG is usually subnormal (often unrecordable in severe cases) and there is no trend for the N95:P50 ratio to reduce with increasing PIOO component latency, i.e. N95 is not reduced in isolation from P50. Note the magnitude of PVEP delay present in some patients. Although it has previously been documented that dysfunction of the central retina may give a delayed PVEP, 3 2, 34 -37 this continues to be overlooked in some clinical practice; it is not correct to assume that a delayed PVEP is synonymous with optic nerve disease. In an early series of 67 patients (incorpo rated in the present data), all 84 eyes with delayed PVEP due to visual pathway dysfunction distal to the optic nerve had abnormalities of the P50 component of the PERG? 3 Some patients had lens opacities, amblyopia or refractive error as a cause of the PVEP delay. Optic disc swelling of unknown cause pre cipitated referral in some patients, and in such circumstances examination of ERG, PERG and VEP is recommended? 8 It should be remembered that papilloedema due to increased intracranial pressure (rCP) does not cause a PVEP abnormality unless secondary optic atrophy has occurred. If an abnormality is present, this reflects the underlying lesion responsible for the rise in ICP? 9 , 40
The (full-field) ERG and PERG have a comple mentary role in diseases of the retina and macula. The PERG enables the direct assessment of central retinal function whereas although the ERG is of great value in the functional assessment of peripheral retinal disease, it is of little diagnostic value in detection of dysfunction confined to the macula. Such a lesion will have a normal ERG, 31 , 33 , 4 1 and the role of the ERG is to assess whether there is significant peripheral retinal involvement, i.e. whether the macular dysfunction is part of a general ised retinopathic process. The PERG also has a role in diseases that principally affect peripheral retina, in that it enables the objective assessment of central retinal function, and may reveal clinically unsus pected evidence of early central retinal dysfunction with possible implications for the prognosis regarding the retention of useful visual acuity. There are no long-term follow-up data at present, but this may be a promising line of future research. The PERG is also of particular interest in neuro-ophthalmic patients; as delayed pattern VEPs commonly occur in retinal/macular dysfunction in addition to the more commonly recognised delays found in optic nerve disease, knowledge of the retinal response to pattern stimulation enables a more accurate inter pretation of an abnormal PVEP. It should be remembered that ophthalmoscopy may not necessa rily reveal visible evidence of macular dysfunction; for example, in some cases of cone dystrophy the classical bull's eye maculopathy does not occur, and, if the macular changes are mild or absent, the patient may initially have been referred to a neurologist for exclusion of a neurological cause for their visual loss.
The ability of the electrophysiologist to distinguish between optic nerve and macular disease may provide a valuable contribution to the management of the patient. • nificance to be meaningfully evaluated; this may prevent misdiagnosis in the elderly patient with a non-functioning chromophobe adenoma who pre sents with visual loss and who has early macular changes on ophthalmoscopy. 43
Optic Nerve Disease
The PERG findings in disease of the optic nerve are of great interest. Firstly, optic nerve lesions can be expected eventually to result in retrograde degen eration to the retinal ganglion cells, and if, as has been suggested, the PERG at least partly originates in the retinal ganglion cells, then PERG abnormal ities should occur in relation to optic nerve dysfunc tion. Secondly, from a practical viewpoint in the clinical setting, the PERG is the precursor of the cortical PVEP and gives valuable information regarding the pathways mediating central vision distal to the optic nerve. The PERG and PVEP findings in a series of patients (382 eyes) with optic nerve demyelination appear in Figs. 3 and 4 . Note that all these eyes have an abnormal PVEP latency. Patients with disease of less than 3 weeks' duration have been excluded from this analysis (see below).
The nature of the PERG findings in optic nerve demyelination is completely different from those presented above in dysfunction anterior to the retinal ganglion cells. Most patients, even those with severe delays in the PVEP PlOO, have a normal PSO component of the PERG (Fig. 3) . It is also noteworthy that many patients have a selective reduction confined to the N9S component, as shown by an abnormal N9S:PSO ratio (Fig. 4) , with a trend to a lower N9S:PSO ratio with a greater severity of conduction delay.
The early studies of PERG in optic nerve demyelination confined their attention to the PSO component of the PERG, and reported a variable incidence of abnormality, 32 , 44 -4 7 but Porciatti and Von Berger 46 did note that the negative after potential (N9S) seemed to be more affected than the main positive component. Some authors con cluded that the PERG contributed little significant information. 1 O , 48 Although absent PERGs were reported in some severely affected eyes, 32 , 49 those studies used monocular stimulation, where there are severe problems in controlling fixation in the affected eye, and similar results have not been confirmed by more recent studies using binocular stimulation. Reports of steady-state PERG abnormalities in optic nerve demyelination also appeared. 50 -52 However, when attention was also focused onto the N9S component of the PERG, it became apparent that, if the PERG is abnormal in optic nerve disease, the abnormality may be confined to the N9S component. 4 , 1 8 ,1 9 In a previous study of eyes with optic nerve demyelination 52 only 40% of PERGs were abnormal, but 85% of these abnorm alities were in relation to the N9S component of the PERG, with no involvement of PSO. The findings of that study are confirmed and extended by the current data.
It should also be noted that there may be a marked A few eyes with very severely abnormal PVEPs have involvement of the P50 component of the PERG (Fig. 5) , but that the majority of eyes show a marked reduction in N95:P50 ratio (Fig. 6 ). Other authors have described mean reduction of P50 amplitude in a group of patients including four with juvenile optic atrophy.57 A previous report of a PVEP latency vs PERG N95:P50 ratio in heredo-famllial optic atrophy (N=48) •
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• Patients with optic nerve compression rarely show involvement of the P50 component of the PERG unless there is a severe PVEP abnormality, perhaps with extinction of the P100 component (Fig. 7) . N95 component abnormalities are more frequent, as shown by a reduced N95:P50 ratio (Fig. 8) . One of the patients with an absent PVEP had a large long standing tumour with a visual acuity of no light perception in one eye (the single P50 amplitude point with a value in the region of 1.0 /-LV), but there is still a measurable PERG. It is not this author's experi ence that extinction of the PERG can occur in optic nerve disease, even when very severe, but extinction is not infrequently seen in patients with macular dysfunction (Fig. 1) .
It has previously been suggested that the PERG may be a useful prognostic indicator for final visual outcome in the pre-operative assessment of optic nerve compression. 6 D Results from the author's laboratory (Holder, unpublished observations) con firm the usefulness of the PERG, an abnormal PERG recorded as part of pre-operative assessment presumably demonstrating significant retrograde degeneration to the retinal ganglion cells and suggesting that there will be a lack of significant post -operative improvement.
May be reduced
SUMMARY OF CLINICAL FINDINGS
As is evident from Figs. 3-8 , the magnitude of the PVEP P100 latency delay in optic nerve disease frequently exceeds 15 ms, but the PERG P50 component is rarely abnormal. It is therefore of particular clinical relevance to compare these obser vations with those in patients with delays of similar nature resulting from dysfunction distal to the optic nerve (Figs. 1, 2) , where the P50 component is usually abnormal. It should be noted that the specificity of these findings may depend on the use of a high-contrast stimulus.6l Although latency changes may occasionally occur with optic nerve disease, P50 component latency does not increase but there may be a shortening of P50 component latency. This is associated with marked N95 compo nent loss. These latency observations again contrast with those in anterior dysfunction where P50 component delays can occur, particularly in patients with macular oedema or serous detachment at the macula. 33 The findings are summarised in Table I. The difference in the nature of the PERG abnormality enables the distinction to be made between abnormal PVEPs in optic nerve disease and those in more distal anterior visual pathway dysfunction. An abnormal PVEP with a normal PERG (or an abnormality confined to N95) places the lesion in the optic nerve/ganglion cells. An abnormal PVEP with a moderate or severe P50 component PERG abnormality suggests more distal dysfunction. These findings led to the development of the diagnostic strategy presented in Fig. 9 . It is again noted that these results may apply only when a high-contrast, high-luminance checkerboard stimulus is used, and this type of stimulus is recommended for routine clinical practice.
If there is an abnormal PVEP, and either a normal PERG or a PERG in which the abnormality is confined to N95, then optic nerve disease is suggested. If the P50 component of the PERG is abnormal a full-field ERG is indicated. If this is abnormal there is involvement of the macula as part of generalised retinal dysfunction, but if the ERG is normal dysfunction confined to the macula is implied (assuming that the media are clear and the patient is optimally refracted).
The implications of a misdiagnosis of optic nerve disease cannot be overstressed. The conditions, in the author's experience, that are most likely to be mistaken for optic neuritis are central serous retino pathy and posterior scleritis. In both of these a PERG P50 component abnormality will establish the macula as the site of the dysfunction. It should be remembered that even lack of adequate spectacle correction in a patient referred for PVEP investiga tion of suspected multiple sclerosis can lead to a PVEP delay, and an abnormal PERG P50 will confirm that the dysfunction is anterior to the optic nerve. It was also demonstrated that the delayed PVEP that can occur in patients with myxoedema, originally thought to reflect optic nerve dysfunction, is accompanied by a delayed, reduced PERG, and that both investigations normalise when the patient becomes euthyroid after treatment with thyroxine. 62 This suggested that the delayed PVEP in hypothyr oidism is probably secondary to reversible central retinal dysfunction.
CONCLUDING REMARKS
Much of the data presented were obtained with the Arden gold foil electrode, which, in this author's experience, remains the electrode of choice for PERG recording in adults. The ability of the PERG to help distinguish between optic nerve disease and dysfunction distal to the retinal ganglion cells, and to give an objective assessment of macular function, has significantly increased the value of electrophysiological testing both in the objective assessment of those patients with central visual loss and in those patients with ophthalmoscopic changes at the macula of uncertain significance. PERG recording is recommended in any patient with visual symptoms in whom the PVEP is abnormal, as knowledge of the PERG facilitates a more accurate interpretation of the findings.
